Katie Ewer
Pre-erythrocytic malaria and outbreak pathogens
Recent publications
-
Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccine.
Journal article
McDaniel JR. et al, (2025), The Journal of experimental medicine, 222
-
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against Mycobacterium avium complex subspecies in patients with active Crohn's disease.
Journal article
Sanderson J. et al, (2025), EBioMedicine, 113
-
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>.
Journal article
Ali MS. et al, (2025), NPJ vaccines, 10
-
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.
Journal article
Varley M. et al, (2025), BMJ open, 15
-
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
Journal article
Venkatraman N. et al, (2025), The Lancet Microbe, 100868 - 100868